Clinical trials
Hidradenitis Suppurativa clinical trials
Below are recruiting hidradenitis suppurativa clinical trials, each written for real people, not researchers. We’re tracking 54 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04218422Recruiting
Battlefield-style ear acupuncture for hidradenitis pain
This trial tests a type of ear acupuncture (“battlefield acupuncture”) to reduce pain from hidradenitis suppurativa, a long-term skin condition. You may be eligible if your hidradenitis pain is frequent and your treatments are stable.
Dearborn, MichiganAges 18 years+ - NCT07828860RecruitingPhase 1
Soquelitinib for adults with hidradenitis suppurativa
This trial tests a new oral medication, soquelitinib, in adults with moderate-to-severe hidradenitis suppurativa (HS), the skin condition that causes painful lumps and tunnels. Soquelitinib works by calming the immune system to reduce inflammation. The study aims to see if it is safe and effective.
West Lafayette, IndianaAges 18 years+ - NCT07783542RecruitingPhase 2
Treatment for moderate to severe hidradenitis suppurativa
This study tests a new medication called ORKA-002 to see if it can reduce the number of painful bumps and sores in people with moderate to severe hidradenitis suppurativa (a chronic skin condition). It may be an option for people who have not had success with antibiotic treatments.
Birmingham, AlabamaAges 18–79 - NCT07755670Recruiting
Brain scans to understand hidradenitis suppurativa
This study uses MRI brain scans to see if brain activity differs in people with hidradenitis suppurativa (a painful skin condition) compared to healthy volunteers. It also tracks how treatment affects the brain over 3 months.
Changsha, HunanAges 18–45 - NCT07689188RecruitingPhase 2
Roflumilast foam for hidradenitis suppurativa in teens and adults
This study tests a foam medication (roflumilast 0.3%) applied to the skin to see if it safely reduces hidradenitis suppurativa (HS) bumps and pain in teens and adults. It might help people with mild-to-moderate HS, especially those who haven't tried this foam before.
Missouri City, TexasAges 12 years+ - NCT07659769Recruiting
Global study on hidradenitis suppurativa
This study collects information from people with hidradenitis suppurativa (a skin condition causing painful lumps) to better understand the condition and improve care worldwide.
ZurichAges 14 years+ - NCT07547813RecruitingPhase 2
Testing LAD328 for moderate-to-severe hidradenitis suppurativa
This study tests a new drug called LAD328 for hidradenitis suppurativa (HS), a chronic skin condition with painful lumps and abscesses. The trial is looking for adults with moderate-to-severe HS who haven't responded well to antibiotics to see if this new treatment can help reduce symptoms.
Warsaw, Masovian VoivodeshipAges 18–65 - NCT07489573RecruitingPhase 4
Study of secukinumab for Chinese adults with moderate-to-severe HS
This study tests if a drug called secukinumab (a self-injected biologic) is safe and effective for adults with moderate-to-severe hidradenitis suppurativa (HS) in China. It may help reduce the number of painful HS lesions.
Guangzhou, GuangdongAges 18 years+ - NCT05531747Recruiting
Study of stress in skin stem cells in hidradenitis
This study looks at how “stress” inside skin cells may be connected to hidradenitis suppurativa, a long-term painful skin condition with recurrent bumps and tunnels. Your participation may help researchers understand what drives the disease.
Créteil, Val-de-marneAges 18–99 - NCT07414550Recruiting
Radiation therapy for hard-to-treat hidradenitis suppurativa
This trial tests if low-dose radiation therapy can help people with moderate to severe hidradenitis suppurativa (HS) that hasn't gotten better with other treatments. It's for those with sores in both armpits.
Cherry Hill, New JerseyAges 18 years+ - NCT07384975RecruitingPhase 2
New drug NAV-240 for hidradenitis suppurativa
This trial tests a new drug called NAV-240 for people with hidradenitis suppurativa (HS) who have not had success with antibiotics. The goal is to see if the drug can reduce the number of painful lumps and improve symptoms.
Phoenix, ArizonaAges 18–70 - NCT07244263RecruitingPhase 2
Zasocitinib for hidradenitis suppurativa
This trial tests a new daily pill called zasocitinib for people with moderate to severe hidradenitis suppurativa (HS) who haven't been helped enough by antibiotics. It aims to reduce painful lumps and abscesses.
Scottsdale, ArizonaAges 18 years+ - NCT07244510RecruitingPhase 2
New Treatment for Moderate to Severe Hidradenitis Suppurativa
This trial tests a new medicine called SCT650C for people with moderate to severe hidradenitis suppurativa (HS). The goal is to see if it can reduce painful bumps and abscesses better than current treatments.
Samsun, TurkeyAges 18 years+ - NCT07225569RecruitingPhase 2
Study of a new drug for moderate to severe hidradenitis suppurativa
This trial tests a new medication, SAR445399, for people with moderate to severe hidradenitis suppurativa (HS) who haven't improved with oral antibiotics. It aims to see if the drug safely reduces skin bumps and abscesses.
Scottsdale, ArizonaAges 18 years+ - NCT07213973RecruitingPhase 2
Study of povorcitinib for teens with hidradenitis suppurativa
This trial tests an oral medication called povorcitinib for adolescents aged 12–17 with moderate to severe hidradenitis suppurativa (HS) that hasn't improved with standard treatments like antibiotics. It aims to see how well the drug works and if it's safe.
Birmingham, AlabamaAges 12–17 - NCT06926192Recruiting
Secukinumab plus surgery for moderate to severe hidradenitis suppurativa
This trial tests whether combining the drug secukinumab with surgery can help people with moderate to severe hidradenitis suppurativa (HS). It looks at how well this combination works and if it is safe over a year.
Nanjing, JiangsuAges Up to 80 years - NCT07170917RecruitingPhase 2
Testing a new drug for moderate to severe hidradenitis suppurativa
This trial tests a new drug called Brivekimig for people with moderate to severe hidradenitis suppurativa (HS) who have not gotten enough relief from oral antibiotics. The goal is to see if it can reduce abscesses and inflamed bumps.
Phoenix, ArizonaAges 18 years+ - NCT07155239RecruitingPhase 1
Laser treatment for hidradenitis suppurativa (acne inversa)
This trial tests a 1726-nm laser to reduce inflamed nodules in people with mild to moderate hidradenitis suppurativa (HS). It compares treated and untreated areas to see if the laser helps without affecting the rest of the body.
Rosemead, CaliforniaAges 18–60 - NCT07151937RecruitingPhase 2
Testing LAD191 for moderate to severe hidradenitis suppurativa
This study tests a new medicine called LAD191 for people with moderate to severe hidradenitis suppurativa (HS) who haven't been helped enough by antibiotics. Researchers want to see if LAD191 safely reduces painful bumps and tunnels.
ManisesAges 18–65 - NCT07109765Recruiting
Secukinumab for moderate to severe hidradenitis suppurativa
This study tests a drug called secukinumab (a type of biologic that targets inflammation) for people with moderate to severe hidradenitis suppurativa (HS). It may be an option if you have tried other treatments and they didn't work well.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07049575RecruitingPhase 1
Ruxolitinib cream study for hidradenitis suppurativa
This study tests a cream called ruxolitinib for people with hidradenitis suppurativa (HS). The goal is to see how much of the cream is absorbed when it's applied to a large area of the body.
Phoenix, ArizonaAges 12–75 - NCT07007637Enrolling by invitationPhase 3
Long-Term Safety and Effectiveness of Sonelokimab for Hidradenitis Suppurativa
This study offers long-term treatment with an investigational biologic, sonelokimab, for people with moderate to severe hidradenitis suppurativa who finished an earlier sonelokimab study. The goal is to see if sonelokimab remains safe and effective over time.
Birmingham, AlabamaAges 12 years+ - NCT06932003RecruitingPhase 1/Phase 2
Testing a new tablet for hidradenitis suppurativa
This trial is testing an experimental tablet called LT-002-158 in adults with moderate to severe hidradenitis suppurativa (HS) that hasn't improved enough with standard treatments. The goal is to see if it's safe and helps reduce painful lumps and abscesses.
Beijing, Beijing MunicipalityAges 18–75 - NCT06326476RecruitingEarly Phase 1
Siplizumab injection for moderate to severe hidradenitis suppurativa
This study tests an injected drug called siplizumab for people with moderate to severe hidradenitis suppurativa (HS) that hasn't improved with other treatments. The goal is to see if it safely reduces painful bumps and improves your skin condition.
Birmingham, AlabamaAges 18 years+
Hear when a new Hidradenitis Suppurativa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Hidradenitis Suppurativa trials by city
Studies with a site in or near these metro areas.
Hidradenitis Suppurativa trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for hidradenitis suppurativa?
- Yes. Clin2 currently lists 54 recruiting hidradenitis suppurativa studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hidradenitis suppurativa trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hidradenitis suppurativa trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.